STEPHANIE KINKADE: Open Payments
NPI 1992576607 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $416 · 2025 $261
Food & beverage: $216Education: $45
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $99 |
| Biogen, Inc. | 2 | $50 |
| Lilly USA, LLC | 1 | $45 |
| SHIELD THERAPEUTICS INC | 1 | $34 |
| Boston Scientific Corporation | 1 | $23 |
| Organon LLC | 1 | $10 |
Products named: GEMTESA, ZURZUVAE, MYFEMBREE, ACCRUFER, Bulkamid, NEXPLANON.
Industry payments across TX — which companies pay providers there.
